Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, 201102, China
Location status: Recruiting
NCT Number: NCT07115108
The purpose of this study is to compare the effect of high and ordinary energy density enteral nutrition for improving physical growth and brain cognitive development in infants with congenital heart disease after operation, as well as evaluate the safety of interventions.
Interested in participating?
Request Info0 month–6 month
All sexes
Interventional
Not applicable
Shanghai, Shanghai Municipality, 201102, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
High-energy-density enteral nutrition (100 cal/100 ml) will be administered to infants following surgery for congenital heart disease. The target feeding volume will be determined based on the infant's body weight (80-100 ml/kg), with the volume per feeding and frequency appropriately adjusted.
Other names: High energy density EN
General energy density enteral nutrition (60-88 cal/100 ml) will be administered to infants following surgery for congenital heart disease. The target feeding volume will be determined based on the infant's body weight (80-100 ml/kg), with the volume per feeding and frequency appropriately adjusted.
Other names: General energy density EN
Time frame: 6th month after discharge
WAZ is calculated according to the Chinese child growth curve and cut-offs .It is a statistical index used to assess the nutritional status of children. The physical examination will be conducted by a nurse, and the data will be recorded to one decimal place.
Time frame: Before discharge, 1st month, 3rd month after discharge
WAZ is calculated according to the Chinese child growth curve and cut-offs .It is a statistical index used to assess the nutritional status of children. The physical examination will be conducted by a nurse, and the data will be recorded to one decimal place.
Time frame: Before discharge, 1st month, 3rd month, 6th month after discharge
The Griffiths mental development scales (GMDs) will be used to repeatedly measure the indicators .The Griffiths scales typically yield a Developmental Quotient (DQ) with an average range of 85-115. The higher the scores, the more advanced development relative to age norms in assessed domains (e.g., motor, language, or cognition).
Time frame: Before discharge, 1 month, 3 months, 6 months after discharge
Primarily defined by elevation in fecal calprotectin and Inflammatory cytokines level.The reference range for calprotectin is 0-5 μg/g,inflammatory cytokines is ≤20pg/ml.Exceeding this range will be considered as abnormal gastrointestinal mucosal barrier function.
Time frame: Before discharge, 1 month, 3 months, 6 months after discharge
Albumin is a rich protein in the blood, which mainly reflects the nutritional status.The reference range for albumin is 39-54g/L.If it is not within this range, it will be judged as abnormal.
Time frame: Before discharge, 1 month, 3 months, 6 months after discharge
Blood lipid test is to measure the content of lipids in blood.Blood lipids include total cholesterol(0-5.18mmol/L) and triglycerides(0-1.7mmol/L).If it exceeds the range, it will be considered as abnormal.
Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge
Calculate the caloric intake for enteral feeding according to the Schofeld formula recommended by the European Society for Pediatric and Neonatal Intensive Care (ESPNIC)
Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge
Based on the child's weight and the fluid balance in the previous 24 hours, the total fluid intake for the day is calculated. After subtracting the amount of intravenous drug solution, the amount of enteral nutrition formula is obtained. According to the child's gastrointestinal function, the principle of gradual progress is adopted to rationally allocate the single feeding volume and feeding frequency.
Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge
Incidence of malabsorption (as defined by any of the following criteria): abnormal fecal lactose content; abnormal fecal fat content.The diagnosis will be confirmed by fecal examination.
Time frame: During hospitalization, before discharge, 1 month, 3 months, 6 months after discharge
Any of the following condition: 1. Frequent vomiting (≥ 3 times/d); 2.Abdominal distension; 3. Milk volume did not increase or decreased>3 d; 4. Gastric retention (retention>1/3 of the previous feeding); 5. Unplanned discontinuation of feeding ≥ 2 times; 6. Diarrhea (stool frequency>6 times/d)
Time frame: Before discharge, 1 month, 3 months, 6 months after discharge
NEC diagnosed in stage II and III will be recorded.
Time frame: At the day of discharge, an average of 3 week after surgery
Mechanical ventilation time (days), postoperative CCU hospitalization duration (days), total hospitalization duration (days), hospitalization costs (Yuan), and the incidence of poor wound healing will be recorded.
Contact information is provided by the study sponsor or research team.
Children's Hospital of Fudan University
Other
Effectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease: A Randomized Controlled Study
Acronym: RCT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02728128
Cardiovascular Abnormalities, Cardiovascular Diseases
Aurora, Colorado, United States
View Trial DetailsNCT06711666
Behavior, Behavioral Symptoms
Marseille, France
View Trial DetailsNCT07732244
Aneurysm, Aneurysm Cerebral
Montreal, Quebec, Canada
View Trial DetailsNCT07716488
Cardiovascular Abnormalities, Cardiovascular Diseases
Jena, Germany
View Trial Details